| Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel | European Heart Journal | 2017 | 1.3K |
| Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 | JAMA - Journal of the American Medical Association | 2017 | 957 |
| Stroke | Lancet, The | 2017 | 563 |
| Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases | Gut | 2017 | 508 |
| Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial | Lancet, The | 2017 | 348 |
| Fine-mapping inflammatory bowel disease loci to single-variant resolution | Nature | 2017 | 311 |
| Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial | Lancet Oncology, The | 2017 | 266 |
| Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study | Lancet, The | 2017 | 225 |
| Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study | JAMA Pediatrics | 2017 | 216 |
| First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials | Lancet Oncology, The | 2017 | 193 |
| Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study) | Circulation | 2017 | 182 |
| Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial | Drug Research | 2017 | 160 |
| Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals | Transfusion | 2017 | 159 |
| Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study | Lancet Diabetes and Endocrinology,the | 2017 | 148 |
| Postoperative pain-from mechanisms to treatment | Pain Reports | 2017 | 133 |
| Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity | Nature Reviews Drug Discovery | 2017 | 127 |
| Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity | Pharmacological Research | 2017 | 123 |
| Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2017 | 117 |
| Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits | Nature Communications | 2017 | 105 |
| Aging and cancer: The role of macrophages and neutrophils | Ageing Research Reviews | 2017 | 104 |
| Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults | PLoS Genetics | 2017 | 103 |
| Cohort Profile: The Western Australian Pregnancy Cohort (Raine) Study-Generation 2 | International Journal of Epidemiology | 2017 | 98 |
| Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program) | American Journal of Cardiology | 2017 | 98 |
| Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2 | Journal of Hypertension | 2017 | 97 |
| Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation | Circulation | 2017 | 95 |
